SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-042019
Filing Date
2019-11-08
Accepted
2019-11-08 08:00:32
Documents
2
Period of Report
2019-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stro-8k_20191107.htm 8-K 29509
2 EX-99.1 stro-ex991_6.htm EX-99.1 177362
  Complete submission text file 0001564590-19-042019.txt   208074
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 191202131
SIC: 2836 Biological Products, (No Diagnostic Substances)